Biotech Ariceum Therapeutics Presents Outstanding Data on its First-in-Class Radiopharmaceutical Drug 225Ac-Satoreotide at the European Association of Nuclear Medicine 2024 October 22, 2024
Biotech MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum October 20, 2024
Biotech 111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 – Conference Call to Follow October 18, 2024
Biotech Commit Biologics appoints Mikkel Wandahl Pedersen as Chief Scientific Officer October 16, 2024
Biotech DBN Group Invites Global Agricultural Biotech Companies to Co-create a Leading Innovation Ecosystem at DBN Phoenix International Innovation Park October 15, 2024
Biotech 21st TAITA Annual Conference Explores Taiwan’s AI Era Strategies in the Global Tech Supply Chain October 14, 2024
Biotech Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium on Lung and Airway Fibrosis October 13, 2024